Arkolith/Insider Trading/PEAR/Form 4

Brenner Erin K.

Chief Product Dev. OfficerPear Therapeutics, Inc. (PEAR) · full profile →Form 4 · filed Jan 24, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$10K
Net Open-Market Flow
-$10K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 20, 2023Sell(S)9K$1.13$10K43K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-23-001327) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML